BioCentury
ARTICLE | Company News

Epizyme, GlaxoSmithKline deal

March 10, 2014 7:00 AM UTC

Epizyme will receive a $2 million milestone payment from GlaxoSmithKline under a January 2011 deal in which the companies partnered to discover, develop and commercialize small molecule therapeutics t...